⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL434945 | 0.70 | — | — | |
| SCHEMBL165076 | 0.67 | — | — | |
| SCHEMBL37063 | 0.64 | — | — | |
| SCHEMBL29116848 | 0.64 | — | — | |
| SCHEMBL2857559 | 0.64 | — | — | |
| SCHEMBL8615162 | 0.64 | FDPS (0.50) | — | |
| SCHEMBL8399407 | 0.62 | CTSA (0.50) | — | |
| SCHEMBL17004026 | 0.61 | — | — | |
| SCHEMBL50123 | 0.61 | — | — | |
| SCHEMBL25318739 | 0.61 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 651 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024073678-A2 | PHOSPHOLIPIDS CONTAINING A HETEROCYCLE RING HAVING A TERTIARY AMINE OR AMIDE | OMEGA THERAPEUTICS, INC. (US) | 2024-04-04 | — | — | WO | claimed |
| EP-4314297-A1 | TARGETING ONCOGENTIC MUTATIONS WITH DUAL-CLEAVING ENDONUCLEASE | Specific Biologics Inc. (CA) | 2024-02-07 | — | — | EP | claimed |
| EP-4301859-A1 | ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | Code Biotherapeutics, Inc. (US) | 2024-01-10 | — | — | EP | claimed |
| WO-2022200858-A1 | TARGETING ONCOGENTIC MUTATIONS WITH DUAL-CLEAVING ENDONUCLEASE | SPECIFIC BIOLOGICS INC. (CA) | 2022-09-29 | — | — | WO | claimed |
| WO-2022187586-A1 | ENHANCED TARGETING USING ANTIBODY-OLIGONUCLEOTIDE CONJUGATES | CODE BIOTHERAPEUTICS, INC. (US) | 2022-09-09 | — | — | WO | claimed |
| WO-2017106767-A1 | PRODUCTION OF UNNATURAL NUCLEOTIDES USING A CRISPR/CAS9 SYSTEM | THE SCRIPPS RESEARCH INSTITUTE (US) | 2017-06-22 | — | — | WO | claimed |
| CN-103998454-A | Double-stranded oligonucleotide compounds for the treatment of hearing and balance disorders | QUARK PHARMACEUTICALS INC | 2014-08-20 | — | — | CN | claimed |
| EP-1765844-B1 | PURINE NUCLEOTIDE DERIVATIVES | SOLVELL AS (NO) | 2014-07-30 | — | — | EP | claimed |
| CN-103221055-A | Modulation of TIMP1 and TIMP2 expression | NITTO DENKO CORP | 2013-07-24 | — | — | CN | claimed |
| US-8153609-B2 | Purine nucleotide derivatives | LAURAS AS (NO) | 2012-04-10 | — | — | US | claimed |
| EP-1611249-A4 | OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA | ISIS PHARMACEUTICALS INC (US) | 2006-06-28 | — | — | EP | claimed |
| EP-1611249-A1 | OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA | ISIS PHARMACEUTICALS, INC. (US) | 2006-01-04 | — | — | EP | claimed |
| WO-2004097049-A1 | OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA | ISIS PHARMACEUTICALS, INC. (US) | 2004-11-11 | — | — | WO | claimed |
| WO-2026107101-A2 | COMPOUNDS FOR TARGETING FERREDOXIN 2 (FDX2) IN FRIEDREICH ATAXIA (FRDA) | THE GENERAL HOSPITAL CORPORATION (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026059707-A9 | METHODS FOR CONJUGATING SEQUENCES OF INTEREST TO BEADS IN A SINGLE BULK REACTION | BECTON, DICKINSON AND COMPANY (US) | 2026-05-15 | — | — | WO | disclosed |
| WO-2026090025-A1 | VARIANT RNA-GUIDED CAS12F4 NUCLEASES FOR SINGLE-STRAND CLEAVAGE | INARI AGRICULTURE TECHNOLOGY, INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-0570575-A1 | BICYCLOAZAMACROCYCLOPHOSPHONIC ACID, CONJUGATES, CONTRAST AGENTS AND PREPARATION | THE DOW CHEMICAL COMPANY (US) | 1993-11-24 | — | — | EP | disclosed |
| WO-1993011802-A1 | BICYCLOAZAMACROCYCLOPHOSPHONIC ACID, CONJUGATES, CONTRAST AGENTS AND PREPARATION | THE DOW CHEMICAL COMPANY (US) | 1993-06-24 | — | — | WO | disclosed |
| WO-1993011801-A1 | BICYCLOPOLYAZAMACROCYCLOPHOSPHONIC ACID COMPLEXES, THEIR PREPARATION, CONJUGATES AND RADIOPHARMACEUTICALS | THE DOW CHEMICAL COMPANY (US) | 1993-06-24 | — | — | WO | disclosed |
| EP-0296854-A2 | Method for processing light-sensitive silver halide color photographic material | KONICA CORPORATION (JP) | 1988-12-28 | — | — | EP | disclosed |